High-trans fatty acid and high-sugar diets can cause mice with non-alcoholic steatohepatitis with liver fibrosis and potential pathogenesis
Abstract Background and aims Even Non-alcoholic steatohepatitis (NASH) has been becoming the key role in process of liver fibrosis or cirrhosis, no any NASH involving liver fibrosis mice model which consistent with the mechanisms of fatty acid and glucose metabolism disorder was widely accepted. Her...
Main Authors: | Xin Xin, Bei-Yu Cai, Cheng Chen, Hua-Jie Tian, Xin Wang, Yi-Yang Hu, Qin Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Nutrition & Metabolism |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12986-020-00462-y |
Similar Items
-
An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
by: Wei-Qiang Leow, et al.
Published: (2020-08-01) -
Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
by: J.T. Stefano, et al.
Published: (2015-02-01) -
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis
by: Kristine Griffett, et al.
Published: (2015-04-01) -
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
by: Wesam Bahitham, et al.
Published: (2024-02-01) -
Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model
by: Yoshinaga Aoyama, et al.
Published: (2021-12-01)